Chugai Pharmaceutical Co., Ltd. provided earnings guidance for the first half and full year of fiscal year ending December 31, 2021. For the year, the company expects revenues of JPY 390,229 million, Core operating profit of JPY 165,817 million, Core net income of JPY 121,733 million and Core earnings per share of JPY 73.99. For the full year, the company expects revenues of JPY 800,000 million, Core operating profit of JPY 320,000 million, Core net income of JPY 232,000 million and Core earnings per share of JPY 141.00.